Back to search

National and Kapodistrian University of Athens

Μελέτη του παθογενετικού ρόλου της κυτταροκίνης RANKL σε διαγονιδιακά ζωικά πρότυπα

Abstract

dc:description

Receptor activator of NF-κBligand (RANKL) plays a key role in osteoclast-induced bone resorption across a range of degenerative bone diseases, and its specific inhibition has been recently approved as a treatment for women with postmenopausal osteoporosis at high or increased risk of fracture. In the present study, we generated transgenic mice (TghuRANKL) carrying the human RANKL (huRANKL) genomic region and achieved a physiologically relevant pattern of RANKLoverexpression in order to establish novel genetic models for assessing skeletal pathologies associated with excessive RANKL and for testing clinical therapeutic candidates that inhibit human RANKL. TghuRANKL mice of both sexes developed early onset bone loss, and the levels of huRANKL expression were correlated with bone resorption and disease severity. Low copy Tg5516 mice expressing huRANKL at low levels displayed a mild osteoporotic phenotype as shown by trabecular bone loss. Notably, overexpression of huRANKL, in the medium copy Tg5519 line, resulted in severe early-onset osteoporosis characterized by lack of trabecular bone, ditsruction of the growth plate, increased osteocalstogenesis, bone marrow adiposity, increased bone remodeling and severe cortical bone porosity accompanied by decreased bone strength. An even more severe skeletal phenotype developed in the high copy Tg5520 founder with extensive soft tissue calcification. Notably, the osteopetroticphenotype of mutant mice expressing an inactiveform of the endogenous RANKL proteinwasrescueduponcrossingthese mice with TghuRANKL mice, showingthat the transgenic human RANKL proteinisfullyactive in the mouse. Alendronate at the dose of 1mg/Kg was administrered subcutaneously in the low-copy Tg5516 mice once a week. Our results confirmed that alendronate fully restored the osteoporotic trabecular stucture in Tg5516 mice that exhibits a mild phenotype.These novel huRANKL transgenic models of osteoporosis represent an important advance for understanding the pathogenesis and treatment of high- turnover bone diseases and other disease states caused by excessive RANKL.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Niti, Alexandra
  • Νίτη, Αλεξάνδρα

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36287

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Niti, Alexandra; Νίτη, Αλεξάνδρα. Μελέτη του παθογενετικού ρόλου της κυτταροκίνης RANKL σε διαγονιδιακά ζωικά πρότυπα. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/36287